Association between sociodemographic variables and delayed patient presentation among surgical neuro-oncology patients in Mexico City: a single institution experience - Summary - MDSpire

Association between sociodemographic variables and delayed patient presentation among surgical neuro-oncology patients in Mexico City: a single institution experience

  • By

  • Maria A. Punchak

  • Jose Alfonso Alvarez-Castro

  • Jonathan Ramos Escalante

  • Keren Magaly Aguilar Hidalgo

  • Mauricio Macias Zamarripa

  • Xymena Dominguez Navarrete

  • Fernando Castro Soto

  • Mackenzie Castellanos

  • Sergio Moreno-Jiménez

  • Michael T. Lawton

  • Alfredo Quinones-Hinojosa

  • Sonia Iliana Mejía Pérez

  • September 24, 2024

  • 0 min

Share

Objective:

To describe the demographic and clinical epidemiology of surgical neuro-oncology patients treated at INNN in 2022 and identify specific sociodemographic factors, such as education level and income, associated with more severe clinical presentation.

Key Findings:
  • Median patient age was 48 years, with 60.1% female.
  • 67.8% of patients completed primary to tertiary education, indicating a potential barrier to timely presentation.
  • Median symptom duration prior to presentation was 37 weeks, highlighting delays in seeking care.
  • Median monthly income was 10,269 MXN, which may impact access to healthcare, and median travel distance to INNN was 49 km.
Interpretation:

Lower education, lower income, and greater distance to the hospital are associated with delayed presentation and more severe clinical outcomes in neuro-oncology patients, suggesting a need for targeted interventions.

Limitations:
  • Study conducted at a single institution, limiting generalizability to other settings.
  • Retrospective design may introduce bias in data collection, potentially affecting the reliability of findings.
Conclusion:

Identifying sociodemographic factors can help target interventions, such as educational programs and financial assistance, to reduce delays in clinical presentation among neuro-oncology patients in Mexico.

Original Source(s)

Related Content